renatomilani's leukemia [56 articles] Export

Recent papers added to renatomilani's library classified by the tag leukemia. You can also see everyone's leukemia.

	Direct inhibition of the NOTCH transcription factor complex [My Copy] Nature, Vol. 462, No. 7270. (12 November 2009), pp. 182-188. by Raymond E. Moellering, Melanie Cornejo, Tina N. Davis, et al.Cristina D. Bianco, Jon C. Aster, Stephen C. Blacklow, Andrew L. Kung, D. Gary Gilliland, Gregory L. Verdine, James E. Bradner posted to transcription-factor structure pathway notch leukemia inhibitor by renatomilani on 2009-11-16 18:58:48 as along with 4 people higueruelo gbloeb qshao cchand
	Therapeutic targets in chronic myeloid leukaemia. [My Copy] Hematological oncology, Vol. 25, No. 2. (June 2007), pp. 66-75. by Nicholas B. Heaney, Tessa L. Holyoake posted to review p-gp leukemia by renatomilani on 2009-11-13 17:23:42 as
	ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? [My Copy] Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, Vol. 21, No. 6. (June 2007), pp. 1172-1176. by D. Steinbach, O. Legrand posted to review p-gp leukemia by renatomilani on 2009-11-13 17:23:04 as
	Imatinib resistance in multidrug-resistant K562 human leukemic cells. [My Copy] Leukemia research, Vol. 33, No. 5. (May 2009), pp. 710-716. by Yanina Assef, Fernanda Rubio, Georgina Coló, Silvana del Mónaco, Mónica A. Costas, Basilio A. Kotsias posted to leukemia imatinib by renatomilani on 2009-11-13 13:29:36 as
	Oncogenic RAS Enables DNA Damage- and p53-Dependent Differentiation of Acute Myeloid Leukemia Cells in Response to Chemotherapy [My Copy] PLoS ONE, Vol. 4, No. 11. (5 November 2009), e7768. by Mona Meyer, Daniela Rübsamen, Robert Slany, et al.Thomas Illmer, Kathleen Stabla, Petra Roth, Thorsten Stiewe, Martin Eilers, Andreas Neubauer posted to ras p53 leukemia cancer by renatomilani on 2009-11-12 18:10:31 as
	Selecting optimal second-line tyrosine kinase inhibitor therapy for chronic myeloid leukemia patients after imatinib failure - does the BCR-ABL mutation status really matter? [My Copy] Blood (30 October 2009), blood-2009-08-215939. by Susan Branford, Junia V. Melo, Timothy P. Hughes posted to leukemia inhibitor abl by renatomilani on 2009-11-06 02:02:06 as along with 1 person LeslieMudd
	Dysregulation of bone remodelling by imatinib mesylate [My Copy] Blood (4 November 2009), blood-2009-08-237404. by Kate Vandyke, Stephen Fitter, Andrea L. Dewar, Timothy P. Hughes, Andrew C. W. Zannettino posted to leukemia chemotherapy bone by renatomilani on 2009-11-06 02:01:45 as
	AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance [My Copy] Vol. 16, No. 5. (6 November 2009), pp. 401-412. by Thomas O'Hare, William C. Shakespeare, Xiaotian Zhu, et al.Christopher A. Eide, Victor M. Rivera, Frank Wang, Lauren T. Adrian, Tianjun Zhou, Wei-Sheng Huang, Qihong Xu, Chester A. Metcalf, Jeffrey W. Tyner, Marc M. Loriaux, Amie S. Corbin, Scott Wardwell, Yaoyu Ning, Jeffrey A. Keats, Yihan Wang, Raji Sundaramoorthi, Mathew Thomas, Dong Zhou, Joseph Snodgrass, Lois Commodore, Tomi K. Sawyer, David C. Dalgarno, Michael W. N. Deininger, Brian J. Druker, Tim Clackson posted to structure resistance leukemia inhibitor drug by renatomilani on 2009-11-03 02:26:41 as along with 1 person Nakamichi
	Myeloid leukemia cell differentiation protein (Mcl-1) dependency as a marker for chemotherapy sensitivity [My Copy] SciBX: Science-Business eXchange, Vol. 2, No. 42. (29 October 2009) posted to scibx leukemia chemotherapy by renatomilani on 2009-11-03 02:01:00 as
	Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib [My Copy] Blood (23 October 2009), blood-2008-08-176016. by Roberto M. Lemoli, Valentina Salvestrini, Elisa Bianchi, et al.Francesco Bertolini, Miriam Fogli, Marilina Amabile, Agostino Tafuri, Simona Salati, Roberta Zini, Nicoletta Testoni, Cristina Rabascio, Lara Rossi, Ines Martin-Padura, Fausto Castagnetti, Paola Marighetti, Giovanni Martinelli, Michele Baccarani, Sergio Ferrari, Rossella Manfredini posted to stem-cell resistance leukemia by renatomilani on 2009-11-03 00:40:34 as
	Proteomic and Genetic Approaches Identify Syk as an AML Target [My Copy] Vol. 16, No. 4. (6 October 2009), pp. 281-294. by Cynthia K. Hahn, Jacob E. Berchuck, Kenneth N. Ross, et al.Rose M. Kakoza, Karl Clauser, Anna C. Schinzel, Linda Ross, Ilene Galinsky, Tina N. Davis, Serena J. Silver, David E. Root, Richard M. Stone, Daniel J. DeAngelo, Martin Carroll, William C. Hahn, Steven A. Carr, Todd R. Golub, Andrew L. Kung, Kimberly Stegmaier posted to syk proteome leukemia genome by renatomilani on 2009-10-05 20:22:20 as
	Cell - Attacking Cancer at Its Root [My Copy] posted to leukemia cancer by renatomilani on 2009-09-18 20:41:35 as
	The derivation of diagnostic markers of chronic myeloid leukemia progression from microarray data [My Copy] Blood (4 August 2009), blood-2009-03-212969. by Vivian G. Oehler, Ka Y. Yeung, Yongjae E. Choi, Roger E. Bumgarner, Adrian E. Raftery, Jerald P. Radich posted to leukemia methods microarray statistics tool by renatomilani on 2009-08-05 16:24:13 as
	ERK2, but Not ERK1, Mediates Acquired and “<italic>De novo</italic>” Resistance to Imatinib Mesylate: Implication for CML Therapy [My Copy] PLoS ONE, Vol. 4, No. 7. (1 July 2009), e6124. by Clara I. Aceves-Luquero, Anupriya Agarwal, Juan L. Callejas-Valera, et al.Laura Arias-González, Azucena Esparís-Ogando, Del, Itxaso Bellón-Echeverria, Miguel A. de La cruz-Morcillo, Eva M. Galán Moya, Inmaculada M. Gimeno, Juan C. Gómez, Michael W. Deininger, Atanasio Pandiella, Ricardo S. Prieto posted to drug erk leukemia mapk resistance by renatomilani on 2009-07-01 21:26:01 as
	P-gp activity is a critical resistance factor against AVE9633 and DM4 cytotoxicity in leukaemia cell lines, but not a major mechanism of chemoresistance in cells from acute myeloid leukaemia patients [My Copy] BMC Cancer, Vol. 9 (23 June 2009), 199. by Ruoping Tang, Simy Cohen, Jean-Yves Perrot, et al.Anne-Marie Faussat, Claudia Zuany-Amorim, Zora Marjanovic, Hamid Morjani, Fanny Fava, Elise Corre, Ollivier Legrand, Jean-Pierre Marie posted to drug leukemia p-gp resistance by renatomilani on 2009-06-25 14:13:45 as
	Another nail in the AML coffin [My Copy] Blood, Vol. 113, No. 24. (11 June 2009), pp. 6045-6046. by Camille N. Abboud posted to leukemia by renatomilani on 2009-06-15 21:39:48 as
	Chronic myelogenous leukaemia market [My Copy] Nature Reviews Drug Discovery, Vol. 8, No. 6. (08 May 2009), pp. 447-448. by Shane Storey posted to drug leukemia review by renatomilani on 2009-06-09 02:10:57 as
	The role of microRNA in human leukemia: a review [My Copy] Leukemia, Vol. 23, No. 7. (15 January 2009), pp. 1257-1263. by S. Yendamuri, G. A. Calin posted to leukemia review rnai by renatomilani on 2009-06-09 01:07:03 as along with 1 person valeriehilgers
	RNAi screen for rapid therapeutic target identification in leukemia patients. [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, No. 21. (26 May 2009), pp. 8695-8700. by J. W. Tyner, M. W. Deininger, M. M. Loriaux, et al.B. H. Chang, J. R. Gotlib, S. G. Willis, H. Erickson, T. Kovacsovics, T. O'Hare, M. C. Heinrich, B. J. Druker posted to kinase leukemia rnai signaling by renatomilani on 2009-05-27 12:56:41 as along with 1 person ajaymalik
	Polo-like kinase 1 is overexpressed in acute myeloid leukemia and its inhibition preferentially targets the proliferation of leukemic cells [My Copy] Blood, Vol. 114, No. 3. (16 July 2009), pp. 659-662. by Annelies G. Renner, Cedric Dos Santos, Christian Recher, et al.Christian Bailly, Laurent Creancier, Anna Kruczynski, Bernard Payrastre, Stephane Manenti posted to cell-cycle drug leukemia polo by renatomilani on 2009-05-25 16:13:40 as
	Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia [My Copy] Blood (20 May 2009), blood-2008-10-184515. by Jerome Tamburini, Alexa S. Green, Valerie Bardet, et al.Nicolas Chapuis, Sophie Park, Lise Willems, Madalina Uzunov, Norbert Ifrah, Francois Dreyfus, Catherine Lacombe, Patrick Mayeux, Didier Bouscary posted to leukemia mtor by renatomilani on 2009-05-25 16:13:24 as
	High frequency of PTEN, PI3K and AKT abnormalities in T cell acute lymphoblastic leukemia [My Copy] Blood (20 May 2009), blood-2009-02-206722. by Alejandro Gutierrez, Takaomi Sanda, Ruta Grebliunaite, et al.Arkaitz Carracedo, Leonardo Salmena, Yebin Ahn, Suzanne Dahlberg, Donna Neuberg, Lisa A. Moreau, Stuart S. Winter, Richard Larson, Jianhua Zhang, Alexei Protopopov, Lynda Chin, Pier P. Pandolfi, Lewis B. Silverman, Stephen P. Hunger, Stephen E. Sallan, Thomas A. Look posted to akt leukemia methods pi3k pten screening t-cell by renatomilani on 2009-05-25 16:12:27 as
	Faculty of 1000 Biology \| Charting the molecular network of the drug target Bcr-Abl. [My Copy] posted to drug f1000 leukemia network by renatomilani on 2009-05-14 23:48:20 as
	Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. [My Copy] posted to expression f1000 leukemia microarray network pathway screening stem-cell by renatomilani on 2009-05-10 22:26:53 as
	Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism [My Copy] Blood, Vol. 113, No. 18. (30 April 2009), pp. 4300-4308. by Paola Secchiero, Elisabetta Melloni, Maria G. di Iasio, et al.Mario Tiribelli, Erika Rimondi, Federica Corallini, Valter Gattei, Giorgio Zauli posted to apoptosis expression leukemia notch p53 signaling by renatomilani on 2009-05-01 00:05:25 as
	Charting the molecular network of the drug target Bcr-Abl [My Copy] Proceedings of the National Academy of Sciences, Vol. 106, No. 18. (5 May 2009), pp. 7414-7419. by Marc Brehme, Oliver Hantschel, Jacques Colinge, et al.Ines Kaupe, Melanie Planyavsky, Thomas Köcher, Karl Mechtler, Keiryn L. Bennett, Giulio Superti-Furga posted to bioinformatics inhibitor interaction leukemia methods network protein signaling by renatomilani on 2009-04-23 19:45:18 as along with 2 people mingzhi oelemento
	The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. [My Copy] Nature genetics, Vol. 41, No. 5. (19 May 2009), pp. 553-562. by FANTOM Consortium, Harukazu Suzuki, Alistair R. Forrest, et al.Erik van Nimwegen, Carsten O. Daub, Piotr J. Balwierz, Katharine M. Irvine, Timo Lassmann, Timothy Ravasi, Yuki Hasegawa, Michiel J. de Hoon, Shintaro Katayama, Kate Schroder, Piero Carninci, Yasuhiro Tomaru, Mutsumi Kanamori-Katayama, Atsutaka Kubosaki, Altuna Akalin, Yoshinari Ando, Erik Arner, Maki Asada, Hiroshi Asahara, Timothy Bailey, Vladimir B. Bajic, Denis Bauer, Anthony G. Beckhouse, Nicolas Bertin, Johan Björkegren, Frank Brombacher, Erika Bulger, Alistair M. Chalk, Joe Chiba, Nicole Cloonan, Adam Dawe, Josee Dostie, Pär G. Engström, Magbubah Essack, Geoffrey J. Faulkner, J. Lynn Fink, David Fredman, Ko Fujimori, Masaaki Furuno, Takashi Gojobori, Julian Gough, Sean M. Grimmond, Mika Gustafsson, Megumi Hashimoto, Takehiro Hashimoto, Mariko Hatakeyama, Susanne Heinzel, Winston Hide, Oliver Hofmann, Michael Hörnquist, Lukasz Huminiecki, Kazuho Ikeo, Naoko Imamoto, Satoshi Inoue, Yusuke Inoue, Ryoko Ishihara, Takao Iwayanagi, Anders Jacobsen, Mandeep Kaur, Hideya Kawaji, Markus C. Kerr, Ryuichiro Kimura, Syuhei Kimura, Yasumasa Kimura, Hiroaki Kitano, Hisashi Koga, Toshio Kojima, Shinji Kondo, Takeshi Konno, Anders Krogh, Adele Kruger, Ajit Kumar, Boris Lenhard, Andreas Lennartsson, Morten Lindow, Marina Lizio, Cameron Macpherson, Norihiro Maeda, Christopher A. Maher, Monique Maqungo, Jessica Mar, Nicholas A. Matigian, Hideo Matsuda, John S. Mattick, Stuart Meier, Sei Miyamoto, Etsuko Miyamoto-Sato, Kazuhiko Nakabayashi, Yutaka Nakachi, Mika Nakano, Sanne Nygaard, Toshitsugu Okayama, Yasushi Okazaki, Haruka Okuda-Yabukami, Valerio Orlando, Jun Otomo, Mikhail Pachkov, Nikolai Petrovsky, Charles Plessy, John Quackenbush, Aleksandar Radovanovic, Michael Rehli, Rintaro Saito, Albin Sandelin, Sebastian Schmeier, Christian Schönbach, Ariel S. Schwartz, Colin A. Semple, Miho Sera, Jessica Severin, Katsuhiko Shirahige, Cas Simons, George St Laurent, Masanori Suzuki, Takahiro Suzuki, Matthew J. Sweet, Ryan J. Taft, Shizu Takeda, Yoichi Takenaka, Kai Tan, Martin S. Taylor, Rohan D. Teasdale, Jesper Tegnér, Sarah Teichmann, Eivind Valen, Claes Wahlestedt, Kazunori Waki, Andrew Waterhouse, Christine A. Wells, Ole Winther, Linda Wu, Kazumi Yamaguchi, Hiroshi Yanagawa, Jun Yasuda, Mihaela Zavolan, David A. Hume, Riken Omics Science Center, Takahiro Arakawa, Shiro Fukuda, Kengo Imamura, Chikatoshi Kai, Ai Kaiho, Tsugumi Kawashima, Chika Kawazu, Yayoi Kitazume, Miki Kojima, Hisashi Miura, Kayoko Murakami, Mitsuyoshi Murata, Noriko Ninomiya, Hiromi Nishiyori, Shohei Noma, Chihiro Ogawa, Takuma Sano, Christophe Simon, Michihira Tagami, Yukari Takahashi, Jun Kawai, Yoshihide Hayashizaki posted to expression leukemia network rna transcription by renatomilani on 2009-04-23 19:37:43 as along with 15 people schwartzjmc rdiaz rsaito guhjy hagechouchin443 gdb tonamswish burak YukaH coela mtagaya bertelsen xingxu TRHvidsten antonkratz
	The stem cell factorc-KIT pathway must be inhibited to enable apoptosis induced by BCRABL inhibitors in chronic myelogenous leukemia cells [My Copy] Leukemia, Vol. aop, No. current. by F. Belloc, K. Airiau, M. Jeanneteau, et al.M. Garcia, E. Guérin, E. Lippert, F. Moreau-Gaudry, F. X. Mahon posted to apoptosis leukemia stem-cell by renatomilani on 2009-04-21 05:35:56 as
	Aberrant as well as embryonic pathways in leukaemic stem cells : article : Nature Reports Stem Cells [My Copy] posted to leukemia stem-cell by renatomilani on 2009-04-15 15:21:23 as
	Jak2 inhibition deactivates Lyn kinase through the SETPP2ASHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients [My Copy] Oncogene, Vol. aop, No. current. by A. K. Samanta, S. N. Chakraborty, Y. Wang, et al.H. Kantarjian, X. Sun, J. Hood, D. Perrotti, R. B. Arlinghaus posted to apoptosis cancer drug jak-stat kinase leukemia resistance signaling by renatomilani on 2009-04-14 20:00:49 as
	Oncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells [My Copy] PLoS Biology, Vol. 7, No. 3. (1 March 2009), e59. by Amit J. Sabnis, Laurene S. Cheung, Monique Dail, et al.Hio C. Kang, Marianne Santaguida, Michelle L. Hermiston, Emmanuelle Passegué, Kevin Shannon, Benjamin S. Braun posted to cancer leukemia stem-cell by renatomilani on 2009-04-02 18:11:30 as
	Molecular mechanism of violacein-mediated human leukemia cell death. [My Copy] Blood, Vol. 104, No. 5. (1 September 2004), pp. 1459-1464. by C. V. Ferreira, C. L. Bos, H. H. Versteeg, G. Z. Justo, N. Durán, M. P. Peppelenbosch posted to leukemia violacein by renatomilani on 2009-04-01 20:57:03 as
	The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL [My Copy] Blood, Vol. 113, No. 12. (19 March 2009), pp. 2776-2790. by Francesco E. Boccalatte, Claudia Voena, Chiara Riganti, et al.Amalia Bosia, Lucia D'Amico, Ludovica Riera, Mangeng Cheng, Bruce Ruggeri, Ole N. Jensen, Valerie L. Goss, Kimberly Lee, Julie Nardone, John Rush, Roberto D. Polakiewicz, Michael J. Comb, Roberto Chiarle, Giorgio Inghirami posted to leukemia methods proteome signaling by renatomilani on 2009-03-20 20:43:37 as
	Unraveling ALK signaling through phosphoproteomics [My Copy] Blood, Vol. 113, No. 12. (19 March 2009), pp. 2615-2616. by Megan S. Lim posted to leukemia methods proteome signaling by renatomilani on 2009-03-20 20:43:01 as
	PKCbeta is essential for the development of CLL in the TCL1 transgenic mouse model: Validation of PKCbeta as a therapeutic target in CLL. [My Copy] Blood (23 January 2009) by Claudia Holler, Josefina D D. Pinon, Ursula Denk, et al.Christoph Heyder, Sebastian Hofbauer, Richard Greil, Alexander Egle posted to drug kinase leukemia pkc signaling by renatomilani on 2009-03-13 19:58:11 as
	Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia [My Copy] BMC Cancer, Vol. 9 (05 March 2009), 77. by Anne, Bjorn T. Gjertsen posted to apoptosis cell chemotherapy expression gene interaction leukemia microarray by renatomilani on 2009-03-09 16:10:45 as
	MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family [My Copy] Oncogene, Vol. aop, No. current. by L. J. Beverly, H. E. Varmus posted to cancer leukemia by renatomilani on 2009-03-05 21:17:20 as along with 1 person tibbitts
	A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia [My Copy] Proceedings of the National Academy of Sciences, Vol. 106, No. 9. (3 March 2009), pp. 3378-3383. by Qun-Ye Zhang, Jian-Hua Mao, Ping Liu, et al.Qiu-Hua Huang, Jing Lu, Yin-Yin Xie, Lin Weng, Yan Zhang, Quan Chen, Sai-Juan Chen, Zhu Chen posted to cancer drug leukemia systems by renatomilani on 2009-03-04 19:52:21 as along with 1 person Schmidtc
	Erythrocytic Casein Kinase II Regulates Cytoadherence of Plasmodium falciparum-infected Red Blood Cells [My Copy] J. Biol. Chem., Vol. 284, No. 10. (6 March 2009), pp. 6260-6269. by Rachna Hora, Daniel J. Bridges, Alister Craig, Amit Sharma posted to ck2 cytoadherence leukemia malaria stem-cell by renatomilani on 2009-02-27 18:33:40 as
	Molecular biology of BCR-ABL1-positive chronic myeloid leukemia [My Copy] Blood (30 September 2008), blood-2008-03-144790. by Alfonso Quintas-Cardama, Jorge Cortes posted to inhibitor kinase leukemia review tyrosine by renatomilani on 2009-02-20 01:11:57 as along with 3 people lrust rajeevsat cer05
	The effect of the dual Src/Abl kinase inhibitor AZD0530 on Philadelphia positive leukaemia cell lines [My Copy] BMC Cancer, Vol. 9 (13 February 2009), 53. by Patricia, Oliver G. Ottmann posted to drug inhibitor leukemia methods src by renatomilani on 2009-02-19 19:08:10 as
	Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, No. 9. (3 March 2009), pp. 3396-3401. by R. Majeti, M. W. Becker, Q. Tian, et al.T. L. Lee, X. Yan, R. Liu, J. H. Chiang, L. Hood, M. F. Clarke, I. L. Weissman posted to bioinformatics cancer chip database expression gene leukemia microarray network pathway stem-cell by renatomilani on 2009-02-16 02:20:16 as along with 2 people jfr tibbitts
	Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA) [My Copy] Blood, Vol. 113, No. 6. (5 February 2009), pp. 1294-1303. by Vladimir Grubor, Alex Krasnitz, Jennifer E. Troge, et al.Jennifer L. Meth, B. Lakshmi, Jude T. Kendall, Boris Yamrom, Garrick Alex, Deepa Pai, Nicholas Navin, Lisa A. Hufnagel, Yoon-Ha Lee, Kerry Cook, Steven L. Allen, Kanti R. Rai, Rajendra N. Damle, Carlo Calissano, Nicholas Chiorazzi, Michael Wigler, Diane Esposito posted to evolution genome leukemia methods microarray by renatomilani on 2009-02-11 02:45:08 as
	Metabolomic profiling of drug responses in acute myeloid leukaemia cell lines. [My Copy] PLoS ONE, Vol. 4, No. 1. (2009) by S. Tiziani, A. Lodi, F. L. Khanim, M. R. Viant, C. M. Bunce, U. L. Günther posted to drug leukemia metabolomics profiling by renatomilani on 2009-02-03 19:46:37 as
	Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia [My Copy] Nature (25 January 2009) by Chen Zhao, Alan Chen, Catriona H. Jamieson, et al.Mark Fereshteh, Annelie Abrahamsson, Jordan Blum, Hyog Y. Kwon, Jynho Kim, John P. Chute, David Rizzieri, Michael Munchhof, Todd Vanarsdale, Philip A. Beachy, Tannishtha Reya posted to cancer hedgehog leukemia signaling stem-cell by renatomilani on 2009-02-03 19:43:42 as along with 3 people tonamswish absterga tibbitts
	SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK [My Copy] Blood, Vol. 113, No. 4. (22 January 2009), pp. 846-855. by Yutaka Okawa, Teru Hideshima, Paul Steed, et al.Sonia Vallet, Steven Hall, Ken Huang, John Rice, Amy Barabasz, Brianna Foley, Hiroshi Ikeda, Noopur Raje, Tanyel Kiziltepe, Hiroshi Yasui, Sotaro Enatsu, Kenneth C. Anderson posted to akt cancer drug erk leukemia by renatomilani on 2009-02-03 00:21:46 as
	Stalling cell division keeps leukaemia stem cells going : article : Nature Reports Stem Cells [My Copy] posted to cancer leukemia stem-cell by renatomilani on 2009-01-27 12:04:56 as
	Aurora-A kinase: a novel target of cellular immunotherapy for leukemia [My Copy] Blood, Vol. 113, No. 1. (1 January 2009), pp. 66-74. by Toshiki Ochi, Hiroshi Fujiwara, Koichiro Suemori, et al.Taichi Azuma, Yoshihiro Yakushijin, Takaaki Hato, Kiyotaka Kuzushima, Masaki Yasukawa posted to aurora immunology kinase leukemia by renatomilani on 2009-01-20 11:24:51 as
	AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines [My Copy] Blood (8 December 2008), blood-2008-02-137737. by Dana S. Levy, Jason A. Kahana, Rakesh Kumar posted to akt apoptosis inhibitor leukemia by renatomilani on 2008-12-18 11:45:17 as
	Characteristics and outcome of chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors [My Copy] Blood, Vol. 112, No. 13. (15 December 2008), pp. 4839-4842. by Elias Jabbour, Hagop M. Kantarjian, Dan Jones, et al.Neeli Reddy, Susan O'Brien, Guillermo Garcia-Manero, Jan Burger, Jorge Cortes posted to domain inhibitor kinase leukemia mutation by renatomilani on 2008-12-16 18:35:31 as

Note: You may cite this page as: http://www.citeulike.org/user/renatomilani/tag/leukemia

Result page: 1 2 Next

cancer	227
kinase	213
bioinformatics	189
signaling	170
pathway	153
network	119
review	119
tool	108
microarray	98
methods	96
protein	95
evolution	78
interaction	67
expression	58
gene	58
drug	57
leukemia	56
genome	47
f1000	43
kinome	43
inhibitor	41
metabolism	41
osteogenesis	41
stem-cell	41
bone	40
systems	40
proteome	39
database	36
apoptosis	35
structure	35
statistics	34
age	31
immunology	29
mapk	29
metascience	28
data	27
phosphoproteome	24
sequence	24
akt	23
erk	23
cell	22
cell-cycle	22
metastasis	21
src	20
wnt	20
bmp	19
resistance	19
development	17
malaria	17
chip	16
function	16
p-gp	16
ptp	16
screening	16
tgf-beta	16
adhesion	15
hedgehog	15
modelling	15
module	15
rnai	15
tyrosine	15
fak	14
jnk	14
p53	14
dna	13
neuroscience	13
pepchip	13
r	13
receptor	13
regulation	13
transcription	13
beta-catenin	12
cytoskeleton	12
egfr	12
sam	12
annotation	11
biotech	11
editorial	11
mass-spec	11
mutation	11
biology	10
enzyme	10
groningen	10
inflammation	10
mtor	10
phylogenetics	10
pi3k	10
profiling	10
ubiquitin	10
virus	10
bacteria	9
chemotherapy	9
mesothelioma	9
pten	9
ros	9
bioconductor	8
biomaterials	8
histone	8
melanoma	8
membrane	8
nf-kb	8
pipeline	8
pkc	8
prostate	8
sirtuin	8
smad	8
alignment	7
gsk	7
motif	7
prediction	7
bayes	6
chemoresistance	6
go	6
hiv	6
notch	6
oncogene	6
p38	6
synthetic	6
telomere	6
ampk	5
aurora	5
disease	5
dna-damage	5
graphs	5
kegg	5
lipid-raft	5
nucleus	5
pka	5
prion	5
publishing	5
ras	5
regeneration	5
rna	5
snp	5
t-cell	5
visualization	5
abl	4
archaea	4
cdk	4
computation	4
high-throughput	4
integrin	4
kidney	4
plant	4
polo	4
proteomics	4
transposon	4
vision	4
acetylation	3
camp	3
climate	3
clustering	3
cytochrome	3
domain	3
enrichment	3
eph	3
jobs	3
math	3
microrna	3
molecular	3
ms	3
obesity	3
omics	3
ontology	3
pak	3
parasite	3
rho	3
scaffold	3
schizophrenia	3
scibx	3
simulation	3
specificity	3
transcription-factor	3
vitamin	3
vivax	3
web	3
automation	2
autophagy	2
blood	2
calcium	2
caveolin	2
change	2
cholesterol	2
ck2	2
death	2
diabetes	2
differentiation	2
dynamics	2
electronics	2
exercise	2
fgfr	2
gene-set	2
glycomics	2
heatshock	2
huntington	2
inhibition	2
intellectual-property	2
jak-stat	2
languages	2
map	2
mcf-7	2
metabolomics	2
myc	2
nano	2
neural-network	2
news	2
nos	2
phosphatase	2
pkg	2
pp2a	2
promoter	2
pseudogene	2
radiation	2
repair	2
runx	2
sbml	2
selection	2
signature	2
stress	2
syk	2
teaching	2
tnf	2
vaccine	2
vegf	2
western	2
wiki	2
3d	1
acp	1
allergy	1
angiotensin	1
argumentation	1
asthma	1
atp	1
atpadp	1
autophosphorylation	1
b-cell	1
bcl	1
biomarker	1
boolean	1
brain	1
btk	1
business	1
bzip	1
calmodulin	1
caspases	1
cell_death	1
channel	1
chemistry	1
chemotaxis	1
ch_ip	1
cilia	1
citation	1
classification	1
cofilin	1
commentary	1
connexin	1
cytoadherence	1
cytoscape	1
dementia	1
dengue	1
detection	1
dystrophy	1
ecology	1
education	1
ejaculation	1
endocytosis	1
engineering	1
epigenetics	1
exon	1
foxo	1
fuel	1
fusion	1
gene-therapy	1
genetics	1
gmo	1
g-protein	1
gwas	1
hgt	1
hippocampus	1
hormone	1
hprd	1
imatinib	1
index	1
interview	1
isoform	1
ldl	1
leptin	1
lipid	1
lymphocyte	1
lysosome	1
magic	1
market	1
materials	1
mcmc	1
memory	1
metazoan	1
methylation	1
microsatellite	1
mitochondria	1
mmp	1
networks	1
ode	1
orthologue	1
p21	1
pain	1
philosophy	1
physics	1
pkr	1
podcast	1
primates	1
profiles	1
programming	1
promiscuity	1
ptk	1
recombination	1
referee	1
retrotransposon	1
rls	1
selective-breeding	1
sequencing	1
shp	1
signlaing	1
sleep	1
spectroscopy	1
stat	1
string	1
svm	1
text-mining	1
thyroid	1
tlr	1
tobacco	1
treatment	1
usability	1
violacein	1
wolbachia	1

renatomilani's leukemia [56 articles] Export

renatomilani's tags